当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 现金流量表

科伦药业

(002422)

  

流通市值:430.94亿  总市值:527.36亿
流通股本:13.06亿   总股本:15.98亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金15,512,135,70410,336,605,8075,020,068,00625,272,264,283
  收到的税费返还205,102,054188,459,68186,337,019114,794,300
  收到其他与经营活动有关的现金328,836,758203,590,29477,712,228380,397,499
  经营活动现金流入小计16,046,074,51610,728,655,7825,184,117,25325,767,456,082
  购买商品、接受劳务支付的现金8,281,083,5655,301,731,4542,567,894,83112,405,028,441
  支付给职工以及为职工支付的现金2,805,721,9762,013,620,1141,240,832,4153,487,925,029
  支付的各项税费1,638,688,8411,136,899,242507,186,3512,883,953,841
  支付其他与经营活动有关的现金1,636,137,8021,086,870,095418,819,4122,497,686,927
  经营活动现金流出小计14,361,632,1849,539,120,9054,734,733,00921,274,594,238
  经营活动产生的现金流量净额1,684,442,3321,189,534,877449,384,2444,492,861,844
二、投资活动产生的现金流量:
  收回投资收到的现金20,206,939,31212,641,939,3123,984,820,00011,062,613,927
  取得投资收益收到的现金152,925,359110,526,76927,840,921209,569,216
  处置固定资产、无形资产和其他长期资产收回的现金净额11,340,69910,558,887689,9878,363,821
  处置子公司及其他营业单位收到的现金净额11,898,47811,357,500-36,896,500
  收到的其他与投资活动有关的现金-28,783,0405,000,000-
  投资活动现金流入小计20,383,103,84812,803,165,5084,018,350,90811,317,443,464
  购建固定资产、无形资产和其他长期资产支付的现金1,160,484,894766,900,166412,916,4491,678,259,615
  投资支付的现金20,595,031,61612,554,019,4614,295,505,81911,378,623,171
  取得子公司及其他营业单位支付的现金10,750,00010,750,000-2,510,000
  支付其他与投资活动有关的现金---77,418,669
  投资活动现金流出小计21,766,266,51013,331,669,6274,708,422,26813,136,811,455
  投资活动产生的现金流量净额-1,383,162,662-528,504,119-690,071,360-1,819,367,991
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,797,570,0511,790,370,051-523,336,701
  其中:子公司吸收少数股东投资收到的现金1,797,570,0511,790,370,051-523,336,701
  取得借款收到的现金4,333,248,0911,997,040,0001,403,460,0004,914,109,872
  收到其他与筹资活动有关的现金50,938,71732,542,49027,130,995183,845,972
  筹资活动现金流入小计6,181,756,8593,819,952,5411,430,590,9955,621,292,545
  偿还债务支付的现金2,906,363,7321,496,363,732990,238,7326,593,687,006
  分配股利、利润或偿付利息支付的现金1,110,787,7971,088,476,76825,875,3462,014,622,932
  其中:子公司支付给少数股东的股利、利润240,433,306240,433,306240,000203,053,883
  支付其他与筹资活动有关的现金87,652,02367,127,92947,280,094317,258,713
  筹资活动现金流出小计4,104,803,5522,651,968,4291,063,394,1728,925,568,651
  筹资活动产生的现金流量净额2,076,953,3071,167,984,112367,196,823-3,304,276,106
四、汇率变动对现金及现金等价物的影响-8,625,875-2,186,9653,846,622-12,779,820
五、现金及现金等价物净增加额2,369,607,1021,826,827,905130,356,329-643,562,073
  加:期初现金及现金等价物余额3,944,762,0743,944,762,0743,944,762,0744,588,324,147
  期末现金及现金等价物余额6,314,369,1765,771,589,9794,075,118,4033,944,762,074
补充资料:
  净利润-1,113,856,403-3,361,954,393
  资产减值准备-95,193,323-239,720,800
  固定资产和投资性房地产折旧-595,283,247-1,103,344,257
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-595,283,247-1,103,344,257
  无形资产摊销-61,700,262-101,616,175
  长期待摊费用摊销-10,871,020-16,702,989
  处置固定资产、无形资产和其他长期资产的损失--3,303,447--807,537
  固定资产报废损失---10,953,403
  公允价值变动损失--15,139,177--19,898,352
  财务费用-53,096,611-134,732,016
  投资损失--139,968,737--345,018,134
  递延所得税-22,685,040--79,328,441
  其中:递延所得税资产减少-8,134,110--82,898,340
    递延所得税负债增加-14,550,930-3,569,899
  存货的减少-168,158,307--84,663,344
  经营性应收项目的减少--358,151,820--27,764,076
  经营性应付项目的增加--532,595,551--173,987,201
  其他-80,163,630-178,554,275
  现金的期末余额-5,771,589,979-3,944,762,074
  减:现金的期初余额-3,944,762,074-4,588,324,147
  现金及现金等价物的净增加额-1,826,827,905--643,562,073
公告日期2025-10-312025-08-292025-04-302025-04-24
审计意见(境内)标准无保留意见
TOP↑